Novartis AG is 57.1x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($283.13 B vs $4.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | NVS |
|---|---|---|
| Market cap | $4.96 B | $283.13 B |
| US-listed rank | #1390 | #47 |
| Revenue (latest FY) | $311.00K | - |
| Net income (latest FY) | -$345.91M | - |
| Net margin | -111225.1% | - |
| SEC filings | 763 | 947 |
Novartis AG is 57.1x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($283.13 B vs $4.96 B).
Full pages: Xenon Pharmaceuticals Inc. and Novartis AG, or browse the full rankings.